High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4- hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3806-3811

  Ozaki, Keisuke ^a,b   Sukata, Tokuo ^a,b   Yamamoto, Shinji ^b   Uwagawa, Satoshi ^a,b   Seki, Takaki ^a,b   Kawasaki, Hajime ^a   Yoshitake, Akira ^a   Wanibuchi, Hideki ^b   Koide, Akihiro ^c   Mori, Yukio ^c   Fukushima, Shoji ^b  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PROTEIN P53;

ALLELE; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; GENE MUTATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; DISEASE SUSCEPTIBILITY; GENES, P53; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; URINARY BLADDER NEOPLASMS;

EID: 17644448277     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancer. Science (Washington DC), 253: 49-53, 1991.
3. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
4. Sidransky, D., Eschenbach, A. V., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., and Vogelstein, B. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
5. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T., and Terada, M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52: 1393-1398, 1992.
6. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., and Tainsky, M. A. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
7. Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., and Chang, E. H. Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (Lond.), 348: 747-749, 1990.
8. Malkin, D. p53 and the Li-Fraumeni syndrome. Biochem. Biophys. Acta, 1198: 197-213, 1994.
9. Ito, N., Hiasa, Y., Tamai, A., Okajima, E., and Kitamura, H. Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann, 60: 401-410, 1969.
10. Fukushima, S., Hirose, M., Tsuda, H., Shirai, T., Hirao, K., Arai, M., and Ito, N. Histological classification of urinary bladder cancers in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann, 67: 81-90, 1976.
11. Tamano, S., Hagiwara, A., Suzuki, E., Okada, M., Shirai, T., and Fukushima, S. Time-and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice. Jpn. J. Cancer Res., 82: 650-656, 1991.
12. Hirose, M., Fukushima, S., Hananouchi, M., Shirai, T., Ogiso, T., Takahashi, M., and Ito, N. Different susceptibility of the urinary bladder epithelium of animal species to three nitroso compounds. Gann, 67: 175-189, 1976.
13. Jerry, D. J., Butel, J. S., Donehower, L. A., Paulson, E. J., Cochran, C., Wiseman, R. W., and Medina, D. Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol. Carcinogenesis (Lond.), 9: 175-183, 1994.
14. Stanley, L. A. Molecular aspects of chemical carcinogenesis: the roles for oncogenes and tumor suppressor genes. Toxicology, 96: 173-194, 1995.
15. Ozaki, M., Shibata, M. A., Takahashi, S., Orita, S. I., Kawabe, M., and Shirai, T. Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin. Cancer Lett., 115: 249-255, 1997.
16. Horesovsky, G., Recio, L., Everitt, J., Goldworthy, T., Wolf, D. C., and Walker, C. p53 status in spontaneous and dimethylnitrosamine-induced renal cell tumors from rats. Mol. Carcinogenesis (Lond.), 12: 236-240, 1995.
17. Weghorst, C. M., Dragnev, K. H., Buzard, G. S., Thorne, K. L., Vandeborne, G. F., Vincent, K. A., and Rice, J. M. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors. Cancer Res., 54: 215-219, 1994.
18. Calvert, R. J., Tashiro, Y., Buzard, G. S., Diwan, B. A., and Weghorst, C. M. Lack of p53 point mutations in chemically induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumor. Cancer Lett., 95: 175-180, 1995.
19. Smith, M. L., Teleswarapu, L., Lombardi, B., and Shinozuka, H. Lack of mutations of the p53 tumor suppressor gene in hepatocellular carcinoma induced in rats by a peroxisome proliferator. Mol. Carcinog. (Lond.), 7: 89-93, 1993.
20. Masui, T., Dong, Y., Yamamoto, S., Takada, N., Nakanishi, H., Inada, K., Fukushima, S., and Tatematsu, M. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis (Lond.), 15: 2379-2381, 1994.
21. Yamamoto, S., Masui, T., Murai, T., Mori, S., Oohara, T., Makino, S., Fukushima, S., and Tatematsu, M. Frequent mutations of the p53 gene and infrequent H-and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with A-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis (Lond.), 16: 2363-2368, 1995.
22. Donehower, L. A., Harvey, M., Slagle, B. L., McArther, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
23. Kemp, C. J., Donehower, L. A., Bradley, A., and Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74: 813-822, 1993.
24. Harvey, M., Vogel, H., Morris, D., Bradley, A., Bernstein, A., and Donehower, L. A. A mutant p53 transgene accelerates tumor development in heterozygous but not nullizygous p53-deficient mice. Nat. Genet., 9: 305-311, 1995.
25. Tennant, R. W., French, J. E., and Spalding, J. W. Identifying chemical carcinogenesis and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect., 103: 942-950, 1995.
26. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genetics, 5: 874-879, 1989.
27. Wada, S., Funae, Y., Imaoka, S., Kawamura, M., Kinoshita, Y., Sugimoto, T., and Maekawa, M. Rapid assay of N-butyl-N-(3-carboxybutyl)nitrosamine in rat organs and urine by high-performance liquid chromatography after derivatization. Jpn. J. Cancer Res., 76: 192-196, 1985.
28. Kemp C. J. Hepatocarcinogenesis in p53-deficient mice. Mol. Carcinog. (Lond.), 12: 132-136, 1995.
29. Harvey, M., McArther, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A., and Donehower, L. A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet., 5: 225-229, 1993.
30. Lee, C. C. R., Yamamoto, S., Wanibuchi, H., Wada, S., Sugimura, K., Kishimoto, T., and Fukushima, S. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogene, tumor suppressor genes and cell proliferation. Cancer Res., 57: 4765-4776, 1997.